AUTONOMIX MEDICAL, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
AUTONOMIX MEDICAL, INC. (AMIX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.05% for the 12-month period ending 2025-03-31, per its 10-K filed 2026-05-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-05-27
- AUTONOMIX MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2025 was -0.05%.
- AUTONOMIX MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -11.01%.
- AUTONOMIX MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2025-03-31 | -0.05% 10-K · filed 2026-05-27 |
| 2024-03-31 | -11.01% 10-K · filed 2025-05-29 |
| 2023-03-31 | 0.00% 10-K · filed 2024-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |